Findings from a new meta-analysis suggest these medications may be most effective in improving cognition in Alzheimer disease.
Are you a US-based MD who sees patients with neurologic disorders and who likes to write? Why not blog for NeurologyTimes.com? It's your place to be heard on topics that keep you up at night. Contact us here and we can send you the details.